Immuneering Corp Stock Technical Analysis
| IMRX Stock | USD 4.93 0.03 0.60% |
As of the 16th of February 2026, Immuneering Corp retains the Market Risk Adjusted Performance of (2.39), risk adjusted performance of (0.01), and Standard Deviation of 7.24. Immuneering Corp technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immuneering Corp Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immuneering, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmuneeringImmuneering | Build AI portfolio with Immuneering Stock |
Immuneering Corp Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 17.17 | Strong Buy | 5 | Odds |
Most Immuneering analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immuneering stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immuneering Corp, talking to its executives and customers, or listening to Immuneering conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuneering Corp. Market participants price Immuneering higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immuneering Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Immuneering Corp requires distinguishing between market price and book value, where the latter reflects Immuneering's accounting equity. The concept of intrinsic value - what Immuneering Corp's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Immuneering Corp's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immuneering Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuneering Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immuneering Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Immuneering Corp 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immuneering Corp's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immuneering Corp.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Immuneering Corp on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Immuneering Corp or generate 0.0% return on investment in Immuneering Corp over 90 days. Immuneering Corp is related to or competes with Foghorn Therapeutics, Pyxis Oncology, Nautilus Biotechnology, Zura Bio, Humacyte, Assembly Biosciences, and Enanta Pharmaceuticals. Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates More
Immuneering Corp Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immuneering Corp's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immuneering Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 67.18 | |||
| Value At Risk | (5.64) | |||
| Potential Upside | 8.98 |
Immuneering Corp Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immuneering Corp's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immuneering Corp's standard deviation. In reality, there are many statistical measures that can use Immuneering Corp historical prices to predict the future Immuneering Corp's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (2.40) |
Immuneering Corp February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (2.39) | |||
| Mean Deviation | 3.87 | |||
| Coefficient Of Variation | (3,642) | |||
| Standard Deviation | 7.24 | |||
| Variance | 52.42 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (2.40) | |||
| Maximum Drawdown | 67.18 | |||
| Value At Risk | (5.64) | |||
| Potential Upside | 8.98 | |||
| Skewness | (2.63) | |||
| Kurtosis | 20.3 |
Immuneering Corp Backtested Returns
Immuneering Corp holds Efficiency (Sharpe) Ratio of -0.0374, which attests that the entity had a -0.0374 % return per unit of risk over the last 3 months. Immuneering Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immuneering Corp's Standard Deviation of 7.24, market risk adjusted performance of (2.39), and Risk Adjusted Performance of (0.01) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.0869, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Immuneering Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immuneering Corp is expected to be smaller as well. At this point, Immuneering Corp has a negative expected return of -0.28%. Please make sure to check out Immuneering Corp's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immuneering Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Immuneering Corp has weak predictability. Overlapping area represents the amount of predictability between Immuneering Corp time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immuneering Corp price movement. The serial correlation of 0.21 indicates that over 21.0% of current Immuneering Corp price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.71 |
Immuneering Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immuneering Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immuneering Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Immuneering Corp Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immuneering Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immuneering Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immuneering Corp price pattern first instead of the macroeconomic environment surrounding Immuneering Corp. By analyzing Immuneering Corp's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immuneering Corp's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immuneering Corp specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Net Debt To EBITDA | 0.95 | 0.5 | 0.58 | 0.55 | Intangibles To Total Assets | 0.0689 | 0.13 | 0.12 | 0.0606 |
Immuneering Corp February 16, 2026 Technical Indicators
Most technical analysis of Immuneering help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immuneering from various momentum indicators to cycle indicators. When you analyze Immuneering charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (2.39) | |||
| Mean Deviation | 3.87 | |||
| Coefficient Of Variation | (3,642) | |||
| Standard Deviation | 7.24 | |||
| Variance | 52.42 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | (2.40) | |||
| Maximum Drawdown | 67.18 | |||
| Value At Risk | (5.64) | |||
| Potential Upside | 8.98 | |||
| Skewness | (2.63) | |||
| Kurtosis | 20.3 |
Immuneering Corp February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immuneering stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.18) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 4.97 | ||
| Day Typical Price | 4.95 | ||
| Price Action Indicator | (0.05) | ||
| Market Facilitation Index | 0.17 |
Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.